About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
CancerGRACE's ASCO 2019 Update on Lung Cancer: How Promising is Lurbinectedin for Relapsed SCLC?
By
GRACE
FEATURING
Jack West
,
Benjamin Levy
,
Charu Aggarwal
By
GRACE
FEATURING
Jack West
,
Benjamin Levy
,
Charu Aggarwal
870 views
September 24, 2019
2 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
17:09
Stanford Medicine
New Drugs for Small Cell Lung Cancer
Feat.
M. Das
23:21
OncoAlert
Year in Review: Lung Cancer Radiation Therapy
Feat.
C. Simone
19:22
Northwell Health
Current Treatment Landscape in SCLC
Feat.
N. Seetharamu
17:43
Insights from ELCC 2024
ELCC 2024 Summary: "Combining New Drugs and RT in Lung Cancer&q…
Feat.
D. Zhou
04:28
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Final Survival Data From a Randomized Pha…
Feat.
B. Henning Grønberg
07:03
ASCO 2022 Conference Coverage
ASCO 2022 on Phase 3 ATLANTIS Trial: Analysis of Patients With Relap…
Feat.
A. Navarro
23:37
CECOG Academy
The Role of IO in SCLC
Feat.
M. Jakopovic
21:11
Penn Medicine Abramson Cancer Center
Choline Kinase Targeted NIR Dyes for Intraoperative Molecular Imagin…
Feat.
E. Delikatny
28:56
Nebraska Oncology Society
Nebraska Oncology Society 2022 SCLC Management Updates
Feat.
T. Leal
19:50
Wade Iams
SCLC Updates: Is Twice-Daily Concurrent CRT Still SoC in LS-Disease?…
15:50
Penn Medicine Abramson Cancer Center
Results of the Randomized, Multi-Center Phase 3 ELUCIDATE Trial: Paf…
Feat.
L. Martin
19:30
Penn Medicine Abramson Cancer Center
Phase II Trial of Intraoperative Molecular Imaging of Lung Cancer wi…
Feat.
S. Singhal
05:17
GRACE
ASCO & ESMO Lung Recap: 2L Lurbinectedin in SCLC - Phase 3 Atlan…
Feat.
J. West,
I. Preeshagul,
J. Schiller
10:16
Memorial Sloan Kettering Cancer Center
2021 ASCO Updates on KEYLYNK-013 Study for Newly Diagnosed LS-SCLC: …
Feat.
A. Rimner
11:41
Insights from ELCC 2024
ELCC 2024 Insights: "The Impact of Brain Metastases on Quality …
Feat.
D. Montague
14:42
Bjørn Henning Grønberg
WCLC 2021 Updates on Thoracic Radiotherapy in LS-SCLC
18:53
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on 1L Treatment of ES-SCLC: IO + Chemo - Results fr…
Feat.
N. Seetharamu
11:48
Haobin Chen
Update on SCLC: Morphology, Recalcitrant Cancer, Systemic Therapy
52
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Analysis of Patients With Relapsed SCLC …
Feat.
A. Navarro
16:29
Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities
Case Presentations/Panel Discussion: 68 y/o Male With Stage 4 RCC, 6…
Feat.
M. Ornstein,
C. Calabrese,
A. Kunchok
